home / stock / adpt / adpt news


ADPT News and Press, Adaptive Biotechnologies Corporation From 11/24/25

Stock Information

Company Name: Adaptive Biotechnologies Corporation
Stock Symbol: ADPT
Market: NASDAQ
Website: adaptivebiotech.com

Menu

Get ADPT Alerts

News, Short Squeeze, Breakout and More Instantly...

ADPT - Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation seque...

ADPT - Adaptive Biotechnologies outlines 39%-42% MRD revenue growth outlook for 2025 with accelerating EMR integration

2025-11-06 07:57:08 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade) Adaptive Biotechnologies Co...

ADPT - Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript

2025-11-06 07:56:08 ET Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript

ADPT - Adaptive Biotechnologies GAAP EPS of $0.06 beats by $0.20, revenue of $93.97M beats by $29.32M

2025-11-05 16:39:58 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade) Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference ...

ADPT - Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...

ADPT - Here are the major earnings after the close Wednesday

2025-11-05 10:00:00 ET Major earnings expected after the bell on Wednesday include: QUALCOMM Incorporated ( QCOM ) Energy Transfer LP ( ET ) Lucid Group ( LCID ) AMC Entertainment Holdings ( AMC ) Devon Energy Corporation ( DVN ) Read the fu...

ADPT - Expected US Company Earnings on Wednesday, November 5th, 2025

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

ADPT - Cathie Woods weekly recap: sells AMD, Shopify, builds exposure in Chinese AI, biotech & Netflix

2025-10-27 06:22:13 ET More on ARK Invest ARK Innovation ETF: Time To Go All In ARKW: Curb Your Enthusiasm, This ETF Is Up 100% But Not That Unique ARKK: Trading Into The Wind Buying the dip: Cathie Wood adds Netflix to her portfolio Cathie Wood's Ark...

ADPT - Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial...

ADPT - Cathie Wood's Ark Invest weekly recap: sheds shares in Palantir Technologies, Shopify, Roblox

2025-10-13 05:25:10 ET More on ARK Invest ARK Innovation ETF: Time To Go All In ARKW: Curb Your Enthusiasm, This ETF Is Up 100% But Not That Unique ARKK: Trading Into The Wind Cathie Wood's Ark Invest weekly recap: adds more Alibaba, Baidu, Kodiak AI, Intelli...

Previous 10 Next 10